Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance.
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance.
复制标题
DOI:
10.1016/j.isci.2021.102780
复制
发表时间:
2021-07-23
期刊:
影响因子:
5.8
通讯作者:
Soundararajan V
中科院分区:
文献类型:
--
作者:
Lenehan PJ;Ramudu E;Venkatakrishnan AJ;Berner G;McMurry R;O'Horo JC;Badley AD;Morice W 2nd;Halamka J;Soundararajan V
Patients with COVID-19 can experience symptoms and complications after viral clearance. It is important to identify clinical features of patients who are likely to experience these prolonged effects. We conducted a retrospective study to compare longitudinal laboratory test measurements (hemoglobin, hematocrit, estimated glomerular filtration rate, serum creatinine, and blood urea nitrogen) in patients rehospitalized after PCR-confirmed SARS-CoV-2 clearance (n = 104) versus patients not rehospitalized after viral clearance (n = 278). Rehospitalized patients had lower median hemoglobin levels in the year prior to COVID-19 diagnosis (Cohen's D = −0.50; p = 1.2 × 10−3) and during their active SARS-CoV-2 infection (Cohen's D = −0.71; p = 4.6 × 10−8). Rehospitalized patients were also more likely to be diagnosed with moderate or severe anemia during their active infection (Odds Ratio = 4.07; p = 4.99 × 10−9). These findings suggest that anemia-related laboratory tests should be considered in risk stratification algorithms for patients with COVID-19. Patients rehospitalized after SARS-CoV-2 clearance have distinct laboratory test profiles Rehospitalized patients have lower hemoglobin before and during SARS-CoV-2 infection Rehospitalized patients are more likely to experience anemia during active infection Virology; Pathophysiology
登录
查看更多内容
DOI:
10.1016/j.ajem.2021.03.083
发表时间:
2021-10
期刊:
The American journal of emergency medicine
影响因子:
--
作者:
Oh SM;Skendelas JP;Macdonald E;Bergamini M;Goel S;Choi J;Segal KR;Vivek K;Nair S;Leff J
通讯作者:
Leff J
影响因子:
3.7
作者:
Townsend L;Dyer AH;Jones K;Dunne J;Mooney A;Gaffney F;O'Connor L;Leavy D;O'Brien K;Dowds J;Sugrue JA;Hopkins D;Martin-Loeches I;Ni Cheallaigh C;Nadarajan P;McLaughlin AM;Bourke NM;Bergin C;O'Farrelly C;Bannan C;Conlon N
通讯作者:
Conlon N
影响因子:
64.8
作者:
Mulligan, Mark J.;Lyke, Kirsten E.;Jansen, Kathrin U.
通讯作者:
Jansen, Kathrin U.
影响因子:
7.1
作者:
Mohsenin V
通讯作者:
Mohsenin V
DOI:
10.1038/s41581-020-00356-5
发表时间:
2020-12
期刊:
Nature reviews. Nephrology
影响因子:
--
作者:
Nadim MK;Forni LG;Mehta RL;Connor MJ Jr;Liu KD;Ostermann M;Rimmelé T;Zarbock A;Bell S;Bihorac A;Cantaluppi V;Hoste E;Husain-Syed F;Germain MJ;Goldstein SL;Gupta S;Joannidis M;Kashani K;Koyner JL;Legrand M;Lumlertgul N;Mohan S;Pannu N;Peng Z;Perez-Fernandez XL;Pickkers P;Prowle J;Reis T;Srisawat N;Tolwani A;Vijayan A;Villa G;Yang L;Ronco C;Kellum JA
通讯作者:
Kellum JA